Determines the safety and accuracy of a combination treatment for patients with Clostridium difficile-associated disease (CDD). Combination of the yeast Saccharomyces boulardii with an antibiotic; Relation between CDD episodes and likelihood of further recurrences; Relative risks of patients treated with the combination therapy; Adverse reactions.